Vaccine Development Equipment
-
Manufactured by NovaDigm Therapeutics, Inc.based in USA
NovaDigm's lead development candidate, NDV-31, is the first vaccine to provide preclinical "cross-kingdom" protection against both fungal and bacterial pathogens. In preclinical studies, the vaccine demonstrated protection against both vaginal and bloodstream infections due to the fungal pathogen Candida.2 NDV-3 also was protective in ...
-
Manufactured by JPT Peptide Technologies GmbHbased in GERMANY
Neo-epitopes are important targets for individualized cancer immunotherapy. Recent advancements in next generation sequencing and bioinformatic approaches to predict immunogenicity of neo-epitopes improved target selection for therapy. However, in many cases only a fraction of predicted epitopes generate a specific T-cell response. Therefore, various assay techniques such as ELISpot, ...
-
Manufactured by Novavaxbased in USA
Novavax' saponin-based Matrix-M improves immune responses and enables vaccine dose-sparing. Matrix-M adjuvant is a valuable component of vaccine development, providing multiple immune system enhancements, a well-understood mechanism of action, and robust clinical experience where it was shown to be well tolerated in human studies to ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines has developed prophylactic vaccines for protection against encephalitis caused by the Venezuelan, Eastern and Western Equine Encephalitis ...
-
Manufactured by POP Biotechnologies, Inc. (POP BIO)based in USA
The SNAP (Spontaneous Nanoliposome Antigen Particleization) platform technology is a unique liposome-based system that functions as a potent vaccine adjuvant designed to address functional and practical limitations facing vaccine ...
-
Manufactured by Virica Biotechbased in CANADA
Viral Medicines are the Way of the Future. Gene therapies and vaccines save and protect human life. The COVID-19 pandemic highlights the criticality of vaccine development today and into the future. The pandemic also highlights the challenges drug developers and manufacturers face. To achieve meaningful yields of viral medicines, ...
-
Manufactured by SpyBiotech Limitedbased in UNITED KINGDOM
CMV is the most common virus that most people have never heard of, even though it has now been identified as a high priority for vaccines development by key authorities such as the FDA and Institute of ...
-
Manufactured by Ziphius Vaccines NVbased in BELGIUM
Ziphius Vaccines is a self-amplifying RNA company developing vaccines for infectious diseases and gene supplementation therapies, aiming to create a new generation of medical ...
-
Manufactured by Virometix AGbased in SWITZERLAND
and the only prophylaxis is a monoclonal Ab (palivizumab) restricted to high-risk pediatric patients. With V-306 Virometix offers a differentiated approach to RSV vaccine development. Our vaccine candidate – already in clinical phase I – demonstrates strong, durable, specific and protective immune responses, with minimal risk of ...
-
Manufactured by PHARMAQ AS - part of Zoetisbased in NORWAY
ALPHA JECT micro 1 PD is a monovalent vaccine developed for use in Atlantic salmon, Salmo salar L. It contains inactivated SAV 3 and is documented for use either alone, or simultaneously with PHARMAQ multivalent vaccines. ALPHA JECT micro 1 PD has been optimized through extensive research to reduce mortality, lesions in the heart and ...
-
by BacVax, Inc.based in USA
Current commercial bacterial vaccines use toxin neutralization, capsule targeting, or multiple proteins. While these methods may work in some circumstances, many bacteria do not have toxin or capsule targets, and using several proteins in a vaccine is expensive and opens the opportunity for genetic escape by the bacteria. ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines has developed a VesiculoVax™-vectored vaccine to protect against the arthralgic disease caused by infection with Chikungunya ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic vaccine for herpes simplex virus type-2. This vaccine is designed to ameliorate disease and transmission by preventing HSV-2 reactivation and ...
-
Manufactured by Virometix AGbased in SWITZERLAND
Streptococcus pneumoniae infections cause diseases with considerable morbidity and mortality. Polysaccharide or conjugated vaccines induce serotype-specific antibodies, limiting clinical effectiveness. Emergence of new bacterial serotypes necessitate a new vaccination approach. Virometix is developing an epitope-based, ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines has developed a VesiculoVax™-vectored vaccine to protect against Lassa hemorrhagic ...
-
Manufactured by JPT Peptide Technologies GmbHbased in GERMANY
Clinical peptides and PepMix Peptide Pools are increasingly needed as antigen source for clinical immune monitoring, diagnostics, cell therapy and vaccine development. The diversity of applications and regulatory requirements calls for a flexible, high quality peptide partner. JPT is that partner with its outstanding know-how on peptide ...
-
Manufactured by Auro Vaccines LLCbased in USA
As part of its comprehensive Public Health and Biodefense vaccine franchise, under a license from the Henry M. Jackson Foundation, Auro Vaccines is developing a subunit vaccine (HeV-sG-V) composed of the envelope glycoprotein of Hendra virus for the prevention of Nipah virus (NiV) ...
-
Manufactured by Ardigenbased in POLAND
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines has developed VesiculoVax™-vectored vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by multiple species of filovirus (i.e. Zaire ebolavirus, Sudan ebolavirus and Marburg ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines is developing a GeneVav prime/VesiculoVax™ boost therapeutic vaccine that targets all HCV genotypes for use as an adjunct to drug ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you